0 references
Reply to comment on: Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial
European Journal of Cancer2022Vol. 167, pp. 166–167
Related Papers
- → How to Treat Prostate Cancer With Androgen Deprivation and Minimize Cardiovascular Risk(2021)42 cited
- → Metabolic Complications and Increased Cardiovascular Risks as a Result of Androgen Deprivation Therapy in Men with Prostate Cancer(2011)9 cited
- → Androgen deprivation therapy for prostate cancer(2017)4 cited
- → Uncovering the Metabolic Complications of Androgen Deprivation Therapy in Patients with Prostate Cancer—Where Do We Take it Next?(2015)2 cited
- Complications of androgen deprivation therapy in prostate cancer / a review(2017)